Worldwide 2024 elections pose pivotal shifts in life sciences and healthcare
The outcomes of this year’s US, EU, and UK elections and their downstream effects will lead to drastic changes to…
Featured
-
-
How to adapt to choppy waters in biotech ecosystem
As the US enters a new political era, experts predict that the pharmaceutical and clinical trials industry will have to…
-
Minister for Science champions partnerships with private clinical sector in UK
Lord Patrick Vallance has emphasised plans for a close collaboration between the government and private sector, in line with the…
-
Arrivo targets major depressive disorder in females after early efficacy data
Arrivo BioVentures’ SIRT6 activator SP-624 has been found to significantly reduce symptoms of major depressive disorder (MDD), but only in…
-
US Border Protection warns pharma of risks with incorrect biologic importation
The incorrect transport of biological materials opens the US up to risk of infectious disease and biological threats, says Sean…
-
UAE’s clinical trials space matures with experience from Covid-19
The United Arab Emirates (UAE)’s clinical research landscape, is quickly developing with a regulatory framework coming into place over the…
-
Social media engagement boosts rare disease outreach
Social media has become an excellent tool for targeting specific patients for clinical trials, says Chris Adams, the CEO at…
-
Pharma companies must adapt to keep pace with AI developments, say experts
As artificial intelligence (AI) permeates clinical trial operations more than ever, workforces will have to adapt to the changing tides,…
-
Mapping out strategies to overcome challenges in clinical research
In the backdrop of geopolitical disruptions impacting supply chains in many industries, the healthcare and pharma sectors are facing several…
-
Amgen and MediLink to collaborate on SCLC combination therapy
Amgen and MediLink Therapeutics have agreed to a research and supply collaboration to develop a combination therapy for extensive-stage small…
